Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...

Seasonal influenza, respiratory syncytial virus (RSV), and COVID-19 are actively circulating throughout the United States.

The experts think not. In fact, three experts told Newsweek that 2025 will look much the same as 2024 in terms of COVID-19 risk. Molecular virologist Professor Jonathan Ball, Deputy Vice ...

Adults with COVID-19 may be at higher risk for rapid kidney decline after hospitalization compared with other respiratory ...

The CROSS score accurately predicts the risk of ICU admission for patients with COVID-19 presenting at the emergency room.

New research emphasizes the need for ongoing COVID-19 protection for people with weakened immune systems, with scalable tests ...

The CIA now assesses the virus that causes Covid-19 more likely originated from an accidental lab leak in China, rather than occurring naturally, according to a statement from the agency Saturday ...

The coronavirus behind covid-19 has infected most people in the world, killing around 15 million people and leaving about 400 million individuals with long-term health problems. It also caused the ...

With the acute phase of the Covid-19 pandemic fading even as the coronavirus persists and evolves, a new normal is taking shape around the world. Experts expect cases to rise again this winter.

Paxlovid may offer marginal benefits for low-risk children with COVID-19; however, among high-risk children with COVID-19, Paxlovid is a safe oral option.